HCP Live January 27, 2024
More than half of patients received return-IBD care via telehealth in the post-COVID period, and those with longer drive times were more likely to continue telehealth care.
Presented at the 2024 Crohn’s and Colitis Congress in Las Vegas this weekend, findings from a recent study are reinforcing the viability of telehealth for patient retention, specifically for those with inflammatory bowel disease (IBD).
Although the COVID-19 pandemic necessitated the implementation of telehealth across many healthcare settings, the option to receive remote care is still offered at various institutions in the post-COVID era, prompting speculation about its impact on patient care.
A team of investigators led by Sara Horst, MD, MPH, associate professor in the division of gastroenterology, hepatology, and nutrition at...
Today's Sponsors
Today's Sponsor